mels, excellent questions. I don't think anyone knows the

New Post Public Reply Private Reply Replies (2) Message Board
havasu78 melsdollars #87396
588
mels, excellent questions. I don't think anyone knows the answers.

I thought MDV's RO comments were about covid and not HIV but what do I know.

As for what is going on with Cytodyn and HIV RO testing to support the BLA, I am just as confused as anyone else.

From what I can tell, Cytodyn has never made any coherent, intelligible statement as to why RO testing is a part of the HIV BLA process.

Well, I guess with maybe one exception.

During the last conference call, Dr. Chris Recknor did say the FDA was interested in HIV BLA receptor occupancy testing to set the dose of leronlimab in HIV.

I don't think Recknor was supposed to say that out loud.

It was Recknor's first time on a conference call.

If the FDA was interested in RO for purpose of dosing, Cytodyn could have said that before but I don't think Cytodyn ever did.

I think the reason that Recknor was supposed to keep quiet on that particular subject is because if Cytodyn needs an RO test for the HIV BLA to succeed, then Cytodyn could have a very serious problem with the HIV BLA.

Now of course there is absolutely no reason whatsoever that the FDA should be interested in RO testing as part of the HIV BLA.

There was no RO testing in the HIV clinical trials. Just give the person the medicine and see if the problem gets taken care of.

So it seems inconceivable that Cytodyn could conduct a trial, show the medicine works, and after the trial is completely don and over with, the FDA says "Well, this data is great, and your medicine seems to work great, but we really prefer a trial protocol different than testing the medicine on people to see if it works."

If the FDA really wants RO testing for the HIV BLA, Cytodyn could be in for a long delay.

During the last conference call, I thought I heard the following comments regarding RO test development for HIV BLA:

1) Cytodyn had two companies working on developing RO testing but both failed

2) Kelly and Recknor have a new idea for RO testing which they are working on

3) RO testing is ongoing for HIV trial patients who have continued in the extension phase of the HIV trials.

These different statements contradict each other. How could RO testing be ongoing if 1) the tests are in development, 2) the tests failed, or 3) Kelly and Recknor have a new one?

But hey, I am just totally confused so no surprise I can't figure out what they said in the last conference call.

My suspicion is that the HIV BLA doesn't matter, at least not financially.

Because there is not going to be any leronlimab left for HIV patients anyway.

My suspicion is that an exponential uptake of leronllimab for covid is about to begin.

Maybe there is even a math model in the covid uptake rate posted on this board.

Three weeks ago we had one and only one patient in the phillippines.

Two weeks ago we had 28 patients dosed in the phillippines.

Yesterday the inadvertent reveal of Randy Nicolas private comment says 250 patients this week.

If this rate of exponential uptake continues, next week will see 2500 patient requests in the Phillippines.

And the week after that, 25,000 patient requests in the Phillippines. At which point the Phillippines has pretty much used up all their 200,000 vials.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsium's Inventory Pile Looms Over Weak First Half

Updated Category News Views 134

A warehouse full of bottles is not a balance-sheet fortress when buyers are backing away. Epsium Enterprise’s first-half 2026 report is a rough read: revenue collapsed 51.8% to $1.47 million, gross profit fell to $175,353, and cash slid to $612,761 at June 30. This is not a subtle slowdown. Macau’s premium Chinese-liquor market has been weak on both demand and...

Continue Reading
TSA at 25: Security Mission Meets a Tough Travel Reality

Updated Category News Views 40

Twenty-five years after its birth from catastrophe, TSA is still carrying a job nobody should take lightly. The agency marked its anniversary on November 19, 2026, looking back to the September 11, 2001 attacks that led to federalized aviation screening and a permanent reshaping of how Americans move through airports. This is not the sort of milestone that deserves...

Continue Reading
Leatt Sets Its Virtual 2026 Shareholder Meeting Date

Updated Category News Views 73

A calendar notice is not a catalyst, but ignoring the calendar is how shareholders miss the small moments that matter. Leatt Corporation has scheduled its 2026 virtual annual general meeting of stockholders for Friday, November 20, at 11:00 AM Eastern Time. For holders of OTCQB:LEAT, this is a basic corporate-governance event, not a new product launch or a financial...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 25

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 100

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
Fervo’s 46% Slide Puts Geothermal Claims Under Fire

Updated Category News Views 53

A 46% haircut from an IPO price has a way of stripping the paint off a growth story. Fervo Energy closed at $14.33 after the October 6 report cited in Hagens Berman’s announcement, well below its $27 IPO price from last May. That does not prove the report is right. It does mean NASDAQ:FRVO investors are staring at questions that go straight to the economic spine of...

Continue Reading
Luxor Targets Device Chaos With Kwik IQ Hub Lockers

Updated Category News Views 125

A dead scanner at shift change can make an expensive digital rollout look downright foolish. Luxor Workspaces is aiming squarely at that unglamorous mess with its newly available Kwik IQ Hub smart-locker collection, introduced at the Connected Worker: Manufacturing Summit in Chicago on October 13–15. The pitch is not flashy: put shared radios, scanners, headsets,...

Continue Reading
Hagerty's Fifth Film Win Keeps Its Media Engine Humming

Updated Category News Views 104

A lap record, a camera crew, and five straight trophies make a louder statement than another glossy corporate slogan. Hagerty won Best Journalism Film at the 2026 International Motor Film Awards on Nov. 14, held at the Petersen Automotive Museum in Los Angeles. The company has taken that particular award home five years running, powered again by Jason Cammisa and his...

Continue Reading
Shenzhen’s APEC Moment Puts Pacific Trade Links in Focus

Updated Category News Views 111

A city that once logged eight stock trades in a day is hosting APEC with a very different kind of ledger in view. Shenzhen Stock Exchange began trial operations on December 1, 1990 with one stock, eight trades and roughly 200,000 yuan in turnover. By the end of September 2026, it had 2,908 listed companies and about 42.43 trillion yuan in combined market value. That is...

Continue Reading
M.O.L.I.F.E. Brings Community Inclusion Into Public View

Updated Category News Views 66

A food pantry can reveal more about inclusion than a polished mission statement ever will. M.O.L.I.F.E., Inc. is set to be featured in an educational segment of All Access with Andy Garcia, and the useful part of this story is not the celebrity-host packaging. It is the organization’s insistence that employment, independent living, day programming, residential support,...

Continue Reading

Top 5 Most Recently Viewed Articles

Poxel's Financial Overview: Q3 2024 Highlights and Future Outlook

Updated Category News Views 42

Poxel's Financial Overview: Q3 2024 Highlights and Future Outlook Poxel SA, a clinical-stage biopharmaceutical company, recently released its revenue and cash position for the third quarter of 2024. With a focus on innovative treatments for serious chronic diseases with metabolic pathophysiology, Poxel is making significant strides, particularly in the management of...

Continue Reading
Investor Insights on Tesla's Future and Elon Musk's Strategy

Updated Category News Views 537

Gary Black's Perspective on Tesla's Earnings Call Gary Black, the managing director of Future Fund LLC, has voiced his opinions on the recent earnings call of Tesla Inc. (NASDAQ: TSLA). He pointed out that CEO Elon Musk's remarks regarding the future failed to inspire confidence among investors. Following a mixed quarterly earnings report, the stock's performance...

Continue Reading
Revolutionizing Vehicle Repairs with Innovative Jack System

Updated Category News Views 478

Introduction to an Innovative Jack System In an exciting development for automotive repair enthusiasts and professionals, an inventive mind has created an improved lift or jack system designed specifically for vehicles. This new solution, known as the AUTO DEVICE, promises to revolutionize how we approach changing tires or conducting repair work. What is the AUTO DEVICE?...

Continue Reading
Examining the Current Trends in Options Trading for WFC

Updated Category News Views 128

Understanding Recent Options Trading Trends for Wells Fargo High-profile investors are signaling a bullish trend for Wells Fargo (NYSE: WFC), catching the attention of retail traders who should be mindful of these developments. This surge in trading activity suggests that significant players might possess critical insights that could impact stock performance. Insights...

Continue Reading
ReTo Eco-Solutions: Major Share Combination Announcement

Updated Category News Views 202

Introduction to ReTo Eco-Solutions Share Combination ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has made a significant decision that impacts its shareholders. Known for manufacturing eco-friendly material production equipment, the company announced an important share combination initiative intended to boost the trading value of its Class A shares. By consolidating shares,...

Continue Reading